Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

CBC Group sets up AffaMed, EverInsight merger, eyes IPO

By Jonathan Chan Oct. 20, 2020

Reprints

With Everest Medicines’ $451 million listing now in the rear-view mirror, health care-focused CBC Group is paving the way for another portfolio company to IPO. But, first, a merger.

AffaMed Therapeutics announced last week that it is merging with EverInsight Therapeutics, another biopharmaceutical company. Both firms were founded by CBC, formerly known as C-Bridge Capital.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Chan

China Health Care Writer

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO
Pharmalittle: Ohio attorney general accuses PBMs of price fixing;…
Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price…
With new study data, Intra-Cellular could expand use of…
With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

Recommended Stories